482 related articles for article (PubMed ID: 12506079)
1. Leukocyte trafficking in experimental autoimmune uveitis: breakdown of blood-retinal barrier and upregulation of cellular adhesion molecules.
Xu H; Forrester JV; Liversidge J; Crane IJ
Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):226-34. PubMed ID: 12506079
[TBL] [Abstract][Full Text] [Related]
2. Correlation between enhanced vascular permeability, up-regulation of cellular adhesion molecules and monocyte adhesion to the endothelium in the retina during the development of fatal murine cerebral malaria.
Ma N; Hunt NH; Madigan MC; Chan-Ling T
Am J Pathol; 1996 Nov; 149(5):1745-62. PubMed ID: 8909263
[TBL] [Abstract][Full Text] [Related]
3. Leukocyte diapedesis in vivo induces transient loss of tight junction protein at the blood-retina barrier.
Xu H; Dawson R; Crane IJ; Liversidge J
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2487-94. PubMed ID: 15980240
[TBL] [Abstract][Full Text] [Related]
4. [The onset mechanism of experimental autoimmune uveoretinitis induced by interphotoreceptor retinoid-binding protein].
Usui M
Nippon Ganka Gakkai Zasshi; 1992 Dec; 96(12):1580-607. PubMed ID: 1283051
[TBL] [Abstract][Full Text] [Related]
5. The blood-retinal barrier in experimental autoimmune uveoretinitis. Leukocyte interactions and functional damage.
Greenwood J; Howes R; Lightman S
Lab Invest; 1994 Jan; 70(1):39-52. PubMed ID: 8302017
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of P-selectin and intercellular adhesion molecule-1 after retinal ischemia-reperfusion injury.
Nishiwaki A; Ueda T; Ugawa S; Shimada S; Ogura Y
Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4931-5. PubMed ID: 14578419
[TBL] [Abstract][Full Text] [Related]
7. Ultrastructural pathology of experimental autoimmune uveitis. Quantitative evidence of activation and possible high endothelial venule-like changes in retinal vascular endothelium.
McMenamin PG; Forrester JV; Steptoe RJ; Dua HS
Lab Invest; 1992 Jul; 67(1):42-55. PubMed ID: 1625447
[TBL] [Abstract][Full Text] [Related]
8. Contribution of TNF-alpha to leukocyte adhesion, vascular leakage, and apoptotic cell death in endotoxin-induced uveitis in vivo.
Koizumi K; Poulaki V; Doehmen S; Welsandt G; Radetzky S; Lappas A; Kociok N; Kirchhof B; Joussen AM
Invest Ophthalmol Vis Sci; 2003 May; 44(5):2184-91. PubMed ID: 12714660
[TBL] [Abstract][Full Text] [Related]
9. Involvement of CD44 in leukocyte trafficking at the blood-retinal barrier.
Xu H; Manivannan A; Liversidge J; Sharp PF; Forrester JV; Crane IJ
J Leukoc Biol; 2002 Dec; 72(6):1133-41. PubMed ID: 12488494
[TBL] [Abstract][Full Text] [Related]
10. Expression of cell adhesion molecules on limbal and neovascular endothelium in corneal inflammatory neovascularization.
Zhu SN; Dana MR
Invest Ophthalmol Vis Sci; 1999 Jun; 40(7):1427-34. PubMed ID: 10359324
[TBL] [Abstract][Full Text] [Related]
11. ICAM-1 and VCAM-1 are differentially expressed on blood-retinal barrier cells during experimental autoimmune uveitis.
Dewispelaere R; Lipski D; Foucart V; Bruyns C; Frère A; Caspers L; Willermain F
Exp Eye Res; 2015 Aug; 137():94-102. PubMed ID: 26093277
[TBL] [Abstract][Full Text] [Related]
12. Requirements for passage of T lymphocytes across non-inflamed retinal microvessels.
Xu H; Manivannan A; Liversidge J; Sharp PF; Forrester JV; Crane IJ
J Neuroimmunol; 2003 Sep; 142(1-2):47-57. PubMed ID: 14512163
[TBL] [Abstract][Full Text] [Related]
13. Leukocyte trafficking in experimental autoimmune uveitis in vivo.
Parnaby-Price A; Stanford MR; Biggerstaff J; Howe L; Whiston RA; Marshall J; Wallace GR
J Leukoc Biol; 1998 Oct; 64(4):434-40. PubMed ID: 9766623
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel dendritic cell populations in normal mouse retina.
Xu H; Dawson R; Forrester JV; Liversidge J
Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1701-10. PubMed ID: 17389502
[TBL] [Abstract][Full Text] [Related]
15. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.
Leal EC; Manivannan A; Hosoya K; Terasaki T; Cunha-Vaz J; Ambrósio AF; Forrester JV
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5257-65. PubMed ID: 17962481
[TBL] [Abstract][Full Text] [Related]
16. VEGF increases retinal vascular ICAM-1 expression in vivo.
Lu M; Perez VL; Ma N; Miyamoto K; Peng HB; Liao JK; Adamis AP
Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1808-12. PubMed ID: 10393052
[TBL] [Abstract][Full Text] [Related]
17. The blood-retinal barrier in experimental autoimmune uveoretinitis (EAU): a review.
Greenwood J
Curr Eye Res; 1992; 11 Suppl():25-32. PubMed ID: 1424749
[TBL] [Abstract][Full Text] [Related]
18. Osteopontin is proinflammatory in experimental autoimmune uveitis.
Hikita ST; Vistica BP; Jones HR; Keswani JR; Watson MM; Ericson VR; Ayoub GS; Gery I; Clegg DO
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4435-43. PubMed ID: 17003437
[TBL] [Abstract][Full Text] [Related]
19. The role of advanced glycation end products in retinal microvascular leukostasis.
Moore TC; Moore JE; Kaji Y; Frizzell N; Usui T; Poulaki V; Campbell IL; Stitt AW; Gardiner TA; Archer DB; Adamis AP
Invest Ophthalmol Vis Sci; 2003 Oct; 44(10):4457-64. PubMed ID: 14507893
[TBL] [Abstract][Full Text] [Related]
20. Effects of experimental ocular inflammation on ocular immune privilege.
Ohta K; Wiggert B; Taylor AW; Streilein JW
Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2010-8. PubMed ID: 10440255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
